Enzyme vs Raydium — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Raydium trades at Rp11,213 (market cap Rp3,01T, Rp116,04M 24h volume). The key difference: Raydium is far larger — about 22440.9× Enzyme's market cap, and Raydium's supply is capped (269,5M / 555M RAY (49%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Raydium for 25 Days on average.
| MLN | RAY | |
|---|---|---|
Market Cap | Rp134,13M | Rp3,01T |
Volume (24h) | Rp104,56M | Rp116,04M |
Circulating Supply | 3,3M MLN | 269,5M / 555M RAY (49%) |
Typical Hold Time | 29 Days | 25 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
RAY is trading at Rp11,527 with a market cap of Rp3.05 trillion, showing neutral technical signals amid bearish moving averages. Recent news highlights include surpassing Rp1 quadrillion in trading volume after listings on Robinhood and Revolut, and enabling tokenized SpaceX stock trading on Solana, boosting ecosystem utility.
Outlook is cautiously optimistic due to increased exchange adoption and innovative use cases, but risks include high volatility and regulatory uncertainty. Key opportunities lie in Solana ecosystem growth, while major risks involve market manipulation and liquidity fluctuations.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Raydium (RAY) is an automated market maker (AMM) and liquidity provider built on the Solana blockchain for the Serum decentralized exchange (DEX). Unlike any other AMMs, Raydium provides on-chain liquidity to a central limit orderbook meaning that funds deposited into Raydium are converted into limit orders which sit on Serum’s orderbooks.
Read more on RAY →